CALCA and osteoporosis: Currently, U.S. Food and Drug Administration-approved drugs for osteoporosis treatment included Bisphosphonates (Fuggle et al., 2022), Calcitonin (Li N. et al., 2021), and Denosumab (a human monoclonal antibody) (Kendler et al., 2022).